Skip to content

Pets Enhancing Therapeutics in Intensive Care Units

Visits by Pet Dogs to Patients Admitted to Intensive Care at the Clermont-Ferrand University Hospital: Feasibility Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07159568
Acronym
PET-ICU
Enrollment
21
Registered
2025-09-08
Start date
2025-09-15
Completion date
2027-10-15
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dog Therapy, Intensive Care Unit (ICU) Patients

Keywords

dog therapy

Brief summary

Intensive Care Units (ICUs) are well known for their therapeutic and environmental aggressiveness. Current recommendations for the management of critically ill patients, including the ABCDEF bundle, emphasize family engagement and liberal visitation policies for relatives and loved ones, with the aim of improving patient well-being during their ICU stay. In France, half of all households own a pet. This close relationship between humans and animals explains why animals have long been involved in medical care. The earliest known use of animals in medicine dates back to the 9th century in Belgium, where they were used to assist individuals with mental illness. More recently, companion animal-assisted interventions have attracted growing interest due to their potential diagnostic and/or therapeutic value, as they may enhance the patient experience during hospitalization. The feasibility, safety, and potential benefits of pet visitation policies have mainly been assessed in conventional hospital wards, but remain understudied in the ICU setting. In France, to our knowledge, only three hospitals have allowed pet visits in the ICU, and these occurred outside of any research protocol. The study primary objective is to assess the feasibility of companion dog visits in three medical-surgical ICUs.

Interventions

OTHERPet dog visit

Pet dog visit will take place during dedicated time slots, following prior verification of the dog's hygiene criteria. The dog may stay in the patient's room for a maximum of 15 minutes. After the visit, an evaluation questionnaire will be completed by the healthcare staff and by the relative who accompanied the dog. The patient's evaluation questionnaire will be completed at ICU discharge if patient is able to respond, or at most 28 days after inclusion if the patient remains in the ICU.

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient aged 18 years or older, * Admitted to one of the participating ICUs at Clermont-Ferrand University Hospital (Estaing Adult ICU, Montpied Medical-Surgical ICU, or Montpied Neuro-ICU) with an expected ICU stay of 48 hours or more, * Owner of a companion dog, with family members or relatives able to bring the dog to the ICU.

Exclusion criteria

Patient-related

Design outcomes

Primary

MeasureTime frameDescription
Success of the pet dog visitImmediately after the interventionThe success of the pet dog visit is defined as the entry of the animal into the patient's ICU room under the conditions specified in the study protocol

Secondary

MeasureTime frameDescription
Patient-related safety events regarding infectionsICU discharge (within a maximum of 28 days)New colonization with multidrug-resistant organisms (as assessed upon ICU admission and weekly thereafter); and new ICU-associated infections (as routinely screened according to standard care)
Dog-related events regarding aggression or behavioral issuesImmediately after the interventionAny display of aggression or behavioral issues (as defined by the participating veterinarian, e.g., stupor, withdrawal, uncontrolled barking, urination or defecation) during the ICU visit, regardless of whether the dog ultimately entered the patient's room.
Staff-related events regarding inconvenience or harmImmediately after the interventionAny inconvenience or harm to a member of the healthcare team, regardless of nature (e.g., injury, hygiene issues, noise, or behavioral disturbance) during the ICU visit, regardless of whether the dog ultimately entered the patient's room.
Visit conditions in the case of success (excluding the safety criteria listed above)Immediately after the interventionPrecise duration of the visit in the patient's room (maximum of 15 minutes, as per protocol), any direct contact between the patient and the dog, and the nature of such interaction.
Patient-related safety events regarding inconvenience or harmImmediately after the interventionAny inconvenience or harm to the patient, regardless of nature (including accidental dislodgement or removal of medical equipment/devices such as tracheal tubes, catheters, drains, etc.)
Pre-visit ICU staff satisfaction-related surveyImmediately before the interventionPre-visit survey of ICU staff (including all clinical and non-clinical personnel such as physicians, nurses, therapists, hygiene and cleaning staff, administrative assistants, and supervisors) to assess their opinions and any potential concerns regarding the visit.
Post-visit ICU staff satisfaction-related surveyImmediately after the interventionPost-visit survey of the same ICU staff to assess their opinion and level of satisfaction.
Post-visit satisfaction survey of the patient's relative(s) who accompanied the dogImmediately after the intervention
Patient satisfaction surveyICU discharge (within a maximum of 28 days)
Reasons for potential visit failure (defined as the inability to bring the animal into the patient's ICU room)Immediately before the interventionReasons are defined as : * Non-compliance with local hygiene guidelines and pre-/intra-visit checklists, as developed specifically for this protocol in collaboration with the hospital's infection control team (CLIN). * Non-compliance with local veterinary regulations and pre-visit veterinary checklists as defined in the study protocol (e.g., vaccination status, parasite control, and regular veterinary follow-up). * Patient agitation, defined as a Richmond Agitation-Sedation Scale (RASS) score \> 0 (monitored every 4 hours per standard practice), before or during the visit. * Any other reason preventing the animal from entering the ICU or the patient's room before or during the visit (including patient discharge from ICU before the visit could be scheduled).

Countries

France

Contacts

Primary ContactLise Laclautre
promo_interne_drci@chu-clermontferrand.fr04.73.75.49.63

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026